NYSE: NUS

NU SKIN ENTERPRISES, INC.

CIK 0001021561 · Drugs & Sundries

Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of premium-quality beauty and wellness solutions in nearly 50 markets worldwide. In 2025, our revenue of $1.5 billion was primarily generated by our two primary product categories: beauty products and wellness products. We… About this business →

8-K Filed May 29, 2026 · Period ending May 28, 2026

Summary not yet generated.

8-K Filed May 8, 2026 · Period ending May 6, 2026

Summary not yet generated.

Partner

Trade NUS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed May 8, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed May 7, 2026 · Period ending May 7, 2026

Summary not yet generated.

10-K Filed Feb 13, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 7, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-K Filed Feb 14, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

About NU SKIN ENTERPRISES, INC.

Source: Item 1 (Business) from the 10-K filed February 13, 2026. Description as filed by the company with the SEC.

ITEM 1.

BUSINESS

Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of premium-quality beauty and wellness solutions in nearly 50 markets worldwide. In 2025, our revenue of
$1.5 billion was primarily generated by our two primary product categories: beauty products and wellness products. We operate in the direct selling channel, primarily utilizing person-to-person
marketing to promote and sell our products, including through the use of social and digital platforms.

In addition to our core Nu Skin business, we also explore new areas of
synergistic and adjacent growth through our strategic investment arm known as Rhyz Inc., which we formed in 2018. Our Rhyz businesses primarily consist of consumer, technology and manufacturing companies. In 2025, the Rhyz companies generated
$223.6 million, or 15%, of our 2025 reported revenue (excluding sales to our core Nu Skin business). As discussed further in “Rhyz Companies,” below, in January 2025 we sold one of our Rhyz businesses that accounted for $69.6 million of our
2024 reported revenue. Our Rhyz companies enable us to optimize our cost of goods, improve lead times, diversify our revenue mix, and create synergies for our brands.

In 2025, we generated approximately 26% of our revenue from the
United States (consisting of our Nu Skin United States and Rhyz businesses) and the remainder from our international markets. Given the size of our international operations, our results, as reported in U.S. dollars, are often impacted by
foreign-currency fluctuations; in 2025, our revenue was negatively impacted 0.8% from foreign-currency fluctuations compared to 2024. Our results also can be impacted by global economic, political, demographic and business trends and
conditions.

Read full description ↓

Our operations are subject to various laws and regulations globally, particularly with respect to our product categories and our distribution channel. See